by Tamar Kahn | Business Day | 19 February 2026 | Feb 21, 2026 | Archive, February 2026
Delve into the AIDS Drug Tender Controversy where Motsoaledi points to the DG in the R15.5bn ARV procurement scandal.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Editorial | Business Day | 18 February 2026 | Feb 18, 2026 | Archive, February 2026
Understand the implications of medical negligence compensation reform as R630m claims hinder Eastern Cape healthcare systems.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Ernest Mabuza | TimesLIVE | 17 February 2026 | Feb 17, 2026 | Archive, February 2026
Unions oppose the Gems contribution increase, citing economic unfairness. Learn why audits are being called for.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Duma Boko | Business Day | 17 February 2026 | Feb 17, 2026 | Archive, February 2026
Investigate the current state of malaria financing in Africa and its significance for public health advancement.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Nate Raymond | Reuters | 13 February 2026 | Feb 16, 2026 | Archive, February 2026
Learn about the US childhood vaccine schedule and the legal challenges against changes to routine vaccinations for children.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Gerry Smith | Bloomberg | 13 February 2026 | Feb 16, 2026 | Archive, February 2026
Moderna criticises the FDA as unpredictable, impacting its mRNA flu shot and the future of drug innovation in America.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions